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Abstract
Introduction
Decreased insulin sensitivity blunts the normal increase in gene expression from skeletal
muscle after exercise. In addition, chronic inflammation decreases insulin sensitivity.
Chronic kidney disease (CKD) is an inflammatory state. How CKD and, subsequently, kid-
ney transplantation affects skeletal muscle gene expression after exercise are unknown.
Methods
Study cohort: non-diabetic male/female 4/1, age 52±2 years, with end-stage CKD who
underwent successful kidney transplantation. The following were measured both pre-trans-
plant and post-transplant and compared to normals: Inflammatory markers, euglycemic
insulin clamp studies determine insulin sensitivity, and skeletal muscle biopsies performed
before and within 30 minutes after an acute exercise protocol. Microarray analyses were
performed on the skeletal muscle using the 4x44KWhole Human Genome Microarrays.
Since nuclear factor of activated T cells (NFAT) plays an important role in T cell activation
and calcineurin inhibitors are mainstay immunosuppression, calcineurin/NFAT pathway
gene expression was compared at rest and after exercise. Log transformation was per-
formed to prevent skewing of data and regression analyses comparing measures pre- and
post-transplant performed.
Result
Markers of inflammation significantly improved post-transplantation. Insulin infusion raised
glucose disposal slightly lower post-transplant compared to pre-transplant, but not signifi-
cantly, thus concluding differences in insulin sensitivity were similar. The overall pattern of
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gene expression in response to exercise was reduced both pre-and post-transplant com-
pared to healthy volunteers. Although significant changes were observed among NFAT/Cal-
cineurin gene at rest and after exercise in normal cohort, there were no significant
differences comparing NFAT/calcineurin pathway gene expression pre- and post-
transplant.
Conclusions
Despite an improvement in serum inflammatory markers, no significant differences in glu-
cose disposal were observed post-transplant. The reduced skeletal muscle gene expres-
sion, including NFAT/calcineurin gene expression, in response to a single bout of exercise
was not improved post-transplant. This study suggests that the improvements in inflamma-
tory mediators post-transplant are unrelated to changes of NFAT/calcineurin gene
expression.
Introduction
Normal insulin sensitivity is associated with increased gene expression from skeletal muscle
after exercise [1]. A decrease in insulin sensitivity is associated with decreased gene expression
from skeletal muscle [2, 3]. Chronic kidney disease (CKD) is marked by decrease in insulin
sensitivity [4, 5]. Whether reduced gene expression in skeletal muscle in response to exercise
extends to people with CKD is not known. In addition, transplant is associated with a lowered
inflammatory milieu, whether this decrease is associated with genes related to the immunosup-
pressive medications given to these patients is also not known.
Additionally, chronic inflammatory states promote insulin resistance and CKD is a chronic
inflammatory state [6, 7]. After transplant, inflammation may be reduced both by the addition
of a new kidney and by the immunosuppressive medication that is administered. Successful
kidney transplantation is the best therapy for patients with end-stage CKD [8]; however, there
is a reported 20–30% increased risk in development of new-onset diabetes after transplantation
in the first year after transplant [9, 10]. The rapid development of new onset diabetes after
transplantation (NODAT) within the first year after transplant is not well understood. The
pathogenesis of NODAT is multifactorial including a component of insulin resistance [11].
Commonly used immunosuppression including glucocorticoids and calcineurin inhibitors
have been recognized as contributing to insulin resistance and play a role in the development
of NODAT [12, 13].
This study compares markers of inflammation, measures of glucose homeostasis and skele-
tal muscle gene expression at rest and after a bout of exercise among a cohort of patients with
end-stage renal disease before and after a successful kidney transplant.
Concise Methods
Study cohort
After approval from the Mayo Clinic Institutional Review Board, we conducted a prospective
cohort study of adult, non-diabetic patients scheduled for living donor kidney transplant.
Absence of diabetes and impaired glucose tolerance was documented with a normal 2-hour
oral glucose tolerance test (OGTT) based on the American Diabetes Association (ADA) crite-
ria. Additionally, all patients had screening fasting blood glucose<126 mg/dl and HbA1C
<6.5%. Study patients included only those who were at low immunologic risk for rejection
Exercise Response Pre- and Post Kidney Transplant
PLOS ONE | DOI:10.1371/journal.pone.0160327 August 12, 2016 2 / 13
Competing Interests: The authors have declared
that no competing interests exist.
based on their pre-transplant cross match testing, thus they were all on a rapid steroid taper
immunosuppression protocol. The rapid steroid taper immunosuppression protocol includes
that all patients receive a 5-day tapering course of glucocorticoids (methylprednisolone intra-
venously 500 mg on day 1; 250 mg on day 2; 125 mg on day 3; oral prednisone 60 mg on day 4;
and 30 mg on day 5; then discontinued). Maintenance immunosuppression after transplant
included tacrolimus (a calcineurin inhibitor) and mycophenolate mofetil.
Experimental protocol
The overall study design is shown in Fig 1. Written consent was obtained from study partici-
pants at least 6 weeks prior to the date of kidney transplant. They reported to the Clinical Stud-
ies Infusion Unit at Mayo Clinic in Arizona after an overnight fast and underwent screening
laboratory tests including a complete blood count, serum creatinine, HbA1C, lipid panel, and
cardiopulmonary exercise testing (CPET) to estimate maximum watts at peak oxygen uptake
or VO2peak was performed. One to 3 weeks later, participants returned to the clinic for the
2-hour OGTT. Subsequently, a euglycemic hyperinsulinemic clamp with peripheral skeletal
muscle biopsy was performed at baseline and at the end of the study as described in Fig 1. After
the clamp (both at baseline and after the transplant), the patient underwent ergometry test on
the bicycle with goal to reach 90% of target watts and at the end of which a peripheral skeletal
muscle biopsy was performed. The same set of tests, including ergometry tests and skeletal
muscle biopsy, was performed after 1 month post-transplant. All patients were instructed to
not engage in voluntary exercise for 3 days before each study visit [3].
Euglycemic clamp with muscle biopsy
A 2-hour euglycemic clamp using an insulin infusion rate of 80 mU.m-2.min-1 was performed
as previously described [14, 15]. A primed infusion of 6,6 di-deuterated glucose was started at
-120 minutes to determine the basal rate of glucose metabolism. Sixty minutes after the start of
deuterated glucose, a basal vastus lateralismuscle biopsy was performed. After 60 minutes, an
insulin infusion was started. Fifteen minutes into the insulin infusion, the deuterated glucose
was discontinued. A variable infusion of 20% dextrose enriched with 6,6 di-deuterated glucose
was used to maintain euglycemia and a constant enrichment of the tracer. Enrichment of
plasma glucose with 6,6 di-deuterated glucose was measured by the Center for Clinical and
Translational Science Metabolomics Core at the Mayo Clinic. The rates of glucose appearance
and disappearance were calculated using steady state equations.
Fig 1. Overall design of study.
doi:10.1371/journal.pone.0160327.g001
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Exercise testing
Patients underwent exercise test using a cycle ergometer. Criteria for end of the test were no
further increases in heart rate and a respiratory exchange ratio greater than 1.1. From the
VO2peak test, heart rates at 70 and 90 percent of maximum effort were determined. The acute
exercise bout experiment was designed to elicit gene expression responses in muscle and con-
sisted of 4 sets of exercise, separated by 2 minutes of rest (unloaded pedaling). Patients exer-
cised in each set at 70% of maximum effort for 8 minutes, followed by a 2 minute “sprint” at
90% of maximum effort, with the 2-minute rest interval following. This was repeated 4 times,
for a total of 48 minutes of exercise. The design of the acute exercise bout was identical to one
used previously for healthy volunteers [3].
Muscle biopsy processing and mRNA analysis
RNA was isolated from the vastus lateralismuscle biopsies as previously described [16]. Micro-
array analysis was performed using the 4x44KWhole Human Genome Microarrays (Agilent
Technologies, Palo Alto, CA) as previously described [3]. Data were deposited in the Gene
Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/index.cgi), submission number
GSE68585. To assess the extent to which pre- and post-transplant exercise-induced gene
expression responses differed from responses in healthy control subjects who performed an
identical exercise protocol [3], we performed regression analysis comparing our subjects to
normal controls.
Other analyses
Plasma glucose concentration was determined by the glucose oxidase method on an YSI 2300
STAT plus (YSI INC., Yellow Springs, OH). Plasma insulin was measured by a two-site immu-
noenzymatic assay performed on the DxI 800 automated immunoassay system (Beckman
Instruments, Chaska, MN 55318). Comprehensive metabolic, lipid, cytokine and hemogram
panels were performed by the Biospecimens Accessioning and Processing Core at the Mayo
Clinic in Arizona on pre-transplant, 1 month, 4 months, and 12 months post-transplant fasting
samples. To assess potential changes in inflammation markers, plasma cytokine concentrations
were assayed before and after kidney transplant.
Analytical methods
Glucose and insulin areas under the glucose tolerance curve were calculated by the trapezoid
method. Disposition index was calculated as the change in glucose compared to the change in
insulin over the first 30 minutes of the glucose tolerance test. The statistical significance of dif-
ference between means for in vivo data was determined using paired or non-paired Student’s t-
tests where appropriate. Pearson correlation calculation was used for all correlations presented.
Results
Patient characteristics and inflammatory markers pre- and post-
transplant
Four men and one woman, all of whom were non-diabetic, had end-stage CKD and were
undergoing dialysis, participated in the study (Table 1). Patients before transplant were over-
weight, and body mass index increased slightly but not significantly after transplant. Before
transplant, the patients had elevated triglyceride concentrations, but normal plasma insulin,
glucose, and HbA1c levels. HbA1c levels increased after transplant.
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Plasma IL-10 concentrations increased significantly and plasma TNFα concentrations
decreased significantly after transplant. Other cytokines including leptin and adiponectin dem-
onstrated decrease although not statistically significant.
Exercise characteristics pre- and post-transplant
The CPET was performed pre-transplant and post-transplant and results were compared.
Although all patients reported a level of physical activity above the sedentary level, VO2peak val-
ues before and after transplant were low (Table 2).
Moreover, peak heart rates during the maximal exercise test were far below age-adjusted
predicted maximum heart rates. These variables did not improve following kidney transplant.
Nevertheless, during the acute exercise bout designed to assess gene expression changes in
muscle, all patients were able to successfully complete the 70% and 90% periods of exercise,
repeated 4 times, and this was the case both before and after kidney transplant.
Glucose metabolism and insulin sensitivity pre- and post-transplant
There was no significant difference in glucose tolerance as a result of kidney transplantation.
Although glucose tolerance was somewhat reduced after transplant, neither mean glucose
(193 ± 48 pre vs. 316 ± 102 mM•min post-transplant) nor mean insulin excursion (20.2 ± 4.9
pre vs. 28.0 ± 5.5 nM•min post-transplant (areas under the glucose tolerance curve) were
Table 1. Patient characteristics and inflammatory markers pre- and post-transplant.
Pre-Transplant 1 Month Post-Transplant 4 Months Post-Transplant 12 Months Post-Transplant
Age (y) 52 ± 2
Gender (M/F) 4/1
BMI (kgm-2) 26.4 ± 0.8 26.5 ± 0.8 27.1 ± 0.7 28.0 ± 0.6
Triglycerides (mg/dL) 163 ± 20 222 ± 46 204 ± 29 163 ± 19
Total cholesterol (mg/dL) 188 ± 10 203 ± 13 189 ± 13 153 ± 21
Fasting glucose (mM) 5.20 ± 0.22 5.70 ± 0.16 5.64 ± 0.17 5.61 ± 0.23
Fasting plasma insulin (pM) 47 ± 7 62 ± 13 N.D. N.D.
Creatinine (mg/dL)* 3.26 ± 0.5 1.60 ± 0.1 1.4 ± 0.1 1.52 ±0 .1
Hemoglobin (g/dL)** 11.8 ± 0.6 12.1 ± 0.5 12.7 ± 0.8 13.1 ± 0.9
Hematocrit (%)** 34.7 ± 1.9 36.1 ± 1.4 38.2 ± 2.3 38.9 ± 2.5
HbA1c (%)* 5.4 ± 0.1 5.4 ± 0.1 5.5 ± 0.1 5.7 ± 0.1
IL-2 (pg/mL) 0.48 ± 0.02 0.41 ± 0.04
IL-8 (pg/mL) 11.9 ± 5.2 7.8 ± 1.8
IL-12 (pg/mL) 0.51 ± 0.12 0.65 ± 0.15
IL-1b (pg/mL) 0.29 ± 0.03 0.35 ± 0.05
IL-6 (pg/mL) 1.0 ± 0.2 1.1 ± 0.2
IL-10 (pg/mL) 1.1 ± 0.3 1.8 ± 0.4*
GM-CSF (pg/mL) 23.2 ± 2.3 21.1 ± 4.6
Interferon 0γ (pg/mL) 1.4 ± 0.3 1.4 ± 0.2
Tumor necrosis factor α (pg/mL) 3.6 ± 0.2 2.2 ± 0.3*
Adiponectin (ng/mL) 9835 ± 2961 7101 ± 2182
Leptin (pg/mL) 18.5 ± 10.2 9.4 ± 3.6
Values are given as mean ± SEM. *P < 0.05 versus pre-transplant values, paired t-test. Data are shown as mean ± SEM.
*P < 0.05
**P < 0.01, significant difference among means using repeated measures analysis of variance.
doi:10.1371/journal.pone.0160327.t001
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significantly higher post-transplant. Mean disposition index was 137 ± 8 pre-transplant and
390 ± 264 mM•pM-1 post-transplant. The large variability was due to 1 patient, and when this
value was excluded, post-transplant mean disposition index post-transplant was 127 ± 29
mM•pM-1. There also was no difference in mean Δinsulin (30–0), which was 345 ± 75 and
355 ± 46 pM pre-and post-transplant, respectively.
There was no change in insulin sensitivity among the 5 subjects post-transplant. Mean levels
of plasma insulin achieved during the last 30 minutes of the 2-hour insulin infusion were simi-
lar before and after transplant (775 ± 48 vs. 789 ± 58 pM, pre- vs. post-transplant, respectively).
All patients had normal post-absorptive levels of endogenous glucose production before and
after transplant. Glucose production was suppressed completely before and after transplant by
insulin (Fig 2). Insulin infusion raised glucose disposal to a similar extent before and after
transplant.
Gene expression in skeletal muscle at rest and after a bout of exercise
before and after kidney transplant
Effect of exercise on gene expression in muscle before kidney transplant. Percutaneous
muscle biopsies were obtained at rest and 30 minutes after completing a 48-minute stationary
cycle exercise bout in patients before kidney transplant. There were 1693 probes that changed
by 1.5-fold after exercise, with nominal P 0.05 (data not shown). The 1693 probes were sub-
jected to Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and gene ontology
annotation analysis using the Database for Annotation, Visualization and Integrated Discovery
(DAVID) v6.7. The most significant pathways are shown in S1 Table. Significantly (Benjamini-
Hochberg corrected P< 0.05) enriched KEGG pathways included cytokine-cytokine receptor
interaction, focal adhesion, extracellular matrix-receptor interaction, and TGFβ signaling (S1
Table). Significant gene ontology (GO) pathways (molecular function) included heparin bind-
ing, actin binding, and extracellular matrix structural constituent, among others (S1 Table).
Gene expression in skeletal muscle after kidney transplant at rest. Agilent 4x44K whole
human genome microarrays were used to evaluate differences in basal, resting gene expression
levels in patients before and after kidney transplant. A total of 612 microarray probes were
altered (increased or decreased) greater than 1.5 fold with a nominal P value0.05 (data not
shown). Among the 10 probes with the greatest fold increases in expression after transplant, 4
were for collagen subunits, including COL1A1, COL6A6, COL3A1 (2 probes) and another was
for an integrin binding protein (ITG1BP3 or NRK2). The 612 probes were subjected to KEGG
Table 2. Exercise characteristics of patients.
Pre-Transplant Post-Transplant*
Maximal Exercise Test
VO2peak (mlkg-1min-1) 19.9 ± 2.7 18.7 ± 2.1
Workpeak (Watts) 149 ± 18 136 ± 25
Heart rate peak (BPM) 130 ± 10 125 ± 7
Acute Exercise Bout for gene expression
Predicted 70% heart rate (BPM) 91 ± 7 87 ± 6
Actual 70% heart rate (BPM) 99 ± 6 93 ± 9
Predicted 90% heart rate (BPM) 117 ± 9 112 ± 8
Actual 90% heart rate (BPM) 120 ± 7 131 ± 11
Data are given as mean ± SEM.
*Exercise test performed on average 31 days post-surgery
doi:10.1371/journal.pone.0160327.t002
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Fig 2. Glucosemetabolism in the post-absorptive state and after two hours of insulin infusion in kidney transplant patients
(n = 5) pre-transplant (open bars) and post-transplant (closed bars).Rates of basal and insulin-stimulated glucose disposal are
given in panel A, and rates of basal and insulin-suppressed endogenous glucose production (B) were determined using 6,6 di-
deuterated glucose. An 80 mU/(m2•min) insulin infusion was used. Data are shown as means ± SEM.
doi:10.1371/journal.pone.0160327.g002
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pathway and GO annotation analysis using DAVID. Significantly (Benjamini-Hochberg cor-
rected P< 0.05) enriched KEGG pathways included extracellular matrix-receptor interaction,
focal adhesion, and TGFβ signaling (S1 Table). Significant GO pathways (molecular function)
included extracellular matrix, growth factor binding, calcium ion binding, and PDGF binding.
Gene expression in skeletal muscle after kidney transplant after a bout of exercise. One
month after kidney transplant, patients had a repeat acute exercise bout with muscle biopsies
at rest and 30 minutes after the conclusion of exercise. Microarray analysis revealed 1176 genes
that increased or decreased 1.5-fold with a nominal P value of 0.05 or better. A total of 1176
microarray probes were altered (increased or decreased) greater than 1.5 fold with a nominal P
value0.05. The 1176 probes were subjected to KEGG and GO annotation analyses using
DAVID v6.7. The most significant pathways are shown in S1 Table.
Changes in response to exercise were compared with normative data from the 301 genes
that changed significantly in healthy subjects [3]. Results of these regression analyses are
shown in Fig 3. Both pre- and post-transplant changes were highly correlated with normative
data (Fig 3A and 3B, respectively, r = 0.79 and 0.93, respectively, P< 0.01). However, the
regression coefficients relating normal responses to pre- and post-kidney transplant responses
were 0.74 and 0.70 respectively, which were significantly lower than a value of 1.0 that would
have been expected had results been identical (P< 0.05).To gauge whether post-transplant
exercise responses were altered compared to pre-transplant values, exercise-induced changes
in gene expression were compared by regression analysis and demonstrated high correlation
(Fig 3C, r = 0.92, P< 0.01).
Effect of transplant on resting and after exercise gene expression involved in calci-
neurin/NFAT signaling. To determine whether tacrolimus (calcineurin inhibitor) after kid-
ney transplant could alter exercise-induced changes in genes that are part of the calcineurin/
NFAT signaling (http://www.broadinstitute.org/gsea/msigdb/index.jsp), genes annotated to
this pathway were compared for exercise responses. Results showed that overall, among all 178
genes in this pathway, there was no significant response to exercise in healthy controls or par-
ticipants pre- or post-transplant (data not shown). Examining the 7 genes that increased by at
least 1.5 fold after exercise in healthy controls (2.68 ± 0.74 fold, average) these also were
increased in the pre- and post-transplant condition (2.35 ± 0.42 and 2.51 ± 0.41 fold, respec-
tively) (Table 3).
Examining the 4 calcineurin/NFAT signaling that decreased by at least 1.5 fold after exercise
in healthy controls (0.59 ± 0.02 fold, average) these did not decrease in the pre-transplant con-
dition (0.94 ± 0.05 fold, average). However, there was a reduction in the expression of these
genes post-transplant (0.74 ± 0.06, average) (Table 3).
Discussion
Chronic kidney disease is a pro-inflammatory and insulin-resistant state. In normal subjects,
insulin resistance is associated with abnormal gene expression in skeletal muscle after exercise.
Among our study cohort of non-diabetics pre-kidney transplant, after a successful kidney
transplant, none of the patients developed NODAT. We observed improvement in inflamma-
tory markers post-transplant but no statistical improvement in insulin sensitivity. Reduced
gene expression in skeletal muscle after exercise was present both pre- and post-transplant.
Based on previous reports, we hypothesized that we would see glucose intolerance pre-
transplant, and our patients in fact did have moderately lower insulin sensitivity compared to
healthy controls [4, 5, 17]. We hypothesized that post-transplant we would see an improve-
ment in glucose sensitivity, but this did not happen. Despite a decrease in inflammatory state
post-transplant, insulin sensitivity was not improved. Patients with CKD had evidence of
Exercise Response Pre- and Post Kidney Transplant
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systemic inflammation, suggested by increased plasma leptin and TNFα and decreased adipo-
nectin concentrations, relative to normative data. Post-transplant, a significant decline in
plasma adiponectin, leptin, and TNFαwas observed.
We also hypothesized that transplant and immunosuppression would result in decreased
gene expression from skeletal muscle after exercise secondary to the insulin resistance that
accompanies transplant immunosuppression medications. Among subjects with CKD, gene
expression response to exercise was qualitatively similar to that of healthy volunteers. Robust
responses were observed for a variety of transcription factors and genes involved in angiogene-
sis, thrombospondins, and immediate early response genes. Transcription of genes is identical
to that of healthy volunteers and this may, in part, explain why physical activity can improve
patient outcomes [18]. However, quantitatively the overall gene expression response to exercise
in patients with CKD to that in healthy people was lowered by a factor of about 25–30%.
Whether this reduced response can be attributed to insulin resistance or to other factors associ-
ated with CKD is unknown.
We specifically examined the NFAT/calcineurin pathway genes to see if calcineurin inhibi-
tors decreased expression. This is the pathway through which calcineurin inhibits T-cells and
blocks an immune response to transplant. We did not observe any significant changes from
pre-transplant to post-transplant in the expression of these genes. In other studies, blockade of
calcineurin signaling blocks muscle hypertrophy in the overloaded condition [19]. This may be
independent of expression of NFAT/calcineurin genes [20, 21] and instead might be related to
the cellular localization of MEF2C [19]. However, other effects of immunosuppression with
calcineurin inhibitors cannot be excluded.
With the DAVID analysis of the resting muscle biopsies before and after transplant (inde-
pendent to exercise effects), we see an enrichment for inflammatory (TGF-beta signaling path-
way), extracellular matrix (ECM-receptor interaction) and metabolic (insulin-like growth
factor binding) pathways. DAVID analysis of the significant genes altered by exercise before
Fig 3. Relationships between exercise-induced gene expression changes (delta from basal, resting gene expression) for (A) pre-
transplant patients vs. healthy controls, (B) post-transplant patients vs. healthy controls, and (C) post vs. pre-transplant effects of
exercise. P < 0.01 for correlation. Data were expressed as differences between exercise-induced fold-changes in gene expression in
each of the three comparisons.
doi:10.1371/journal.pone.0160327.g003
Table 3. NFATGene Expression.
Gene
Symbol
Healthy
controls
fold
change
Healthy
controls P
value
Pre-
transplant
fold change
Pre-
transplant
P value
Comparing Pre-
transplant fold
change to
healthy fold
change (P value)
Post-
transplant
fold change
Post-
transplant P
value
Comparing post-
transplant fold
change to
healthy fold
change P value
Comparing pre-
transplant fold
change to post-
transplant fold
change (P value)
CDKN1A 1.56 0.00015 3.65 0.063 0.053806558 3.56 0.0025 0.000772708 0.972211502
NPPA 1.61 0.035 0.86 0.155 0.152388407 1.3 0.29 0.664144399 0.348294588
CDKN1A 1.76 4.6E-06 2.42 0.048 0.252030417 2.38 0.022 0.180687496 0.978413125
EDN1 1.98 0.00038 2.07 0.047 0.895503294 2.33 0.034 0.625909669 0.819630648
FKBP1A 2.27 1.29E-06 1.49 0.075 0.066983948 1.52 0.028 0.056927083 0.934217025
PIM1 2.56 3.41E-07 2.07 0.021 0.362681298 2.15 0.00021 0.355897099 0.86703075
NR4A1 7.02 5.48E-10 3.93 0.0082 0.062345795 4.32 0.000051 0.044233032 0.818356927
PRKAR2B 0.55 0.0027 1.03 0.42 0.063167806 0.84 0.298 0.24181481 0.56765799
PRKCB 0.59 0.048 0.99 0.49 0.344460401 0.61 0.022 0.964624765 0.172838548
MAP3K1 0.61 0.018 0.79 0.095 0.477248431 0.82 0.226 0.436514375 0.868931367
HAND1 0.63 0.036 0.95 0.38 0.331765088 0.67 0.084 0.872455832 0.372859202
doi:10.1371/journal.pone.0160327.t003
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transplant identified a number of pathways involved in extracellular matrix (ECM-receptor
interaction), inflammation (TGF-beta signaling pathway) and cytoskeletal (actin binding)
interactions. Previous studies from our lab have demonstrated alterations in genes and proteins
coding for extracellular matrix remodeling, inflammation and cytoskeletal interactions in the
skeletal muscle of experimental and naturally occurring insulin resistance [16, 22]. These same
pathways remained enriched following exercise after transplant with the exception of actin
binding. There are significantly more pathways enriched in the post-transplant exercise state
compared to the pre-transplant exercise state, and interestingly a large number of these path-
ways are for cytokine and chemokine activity. Since our patients are in recovery phase post-
transplant, it is expected that they are still recovering from their surgery and hence the enrich-
ment for the inflammatory pathways (i.e. cytokine activity and chemokine activity).
Pre-transplant subjects evidenced reduced exercise tolerance with lower than normal values
for peak heart rate, work, and peak oxygen consumption during a maximal exercise test. They
had low hematocrit and blood hemoglobin values, as expected in CKD, potentially reducing
oxygen delivery to tissues during exercise. After transplant, patients showed improvements in a
number of areas. As expected, hematocrit and hemoglobin levels improved; however, post-
transplant we did not observe an improvement in VO2peak. We presume that patients were still
recovering from bed rest. Exercise testing and muscle biopsy after exercise were performed on
average 31 days after surgery. Bed rest is known to cause decrease in skeletal muscle mass pri-
marily due to decrease in protein synthesis but also because of an increase in proteolytic
enzymes. Previous studies of gene expression have shown that both are active in disuse atrophy
[23, 24]. The VO2peak has been shown elsewhere to improve 1 year post-transplant [25].
Although there was improvement in inflammatory markers, insulin sensitivity in our subjects
remained low-normal post-transplant. Calcineurin inhibitor-based immunosuppression and
albeit minimal steroid exposure were probably contributory to low-normal insulin sensitivity
[25]. Decreased insulin sensitivity might explain the continued reduced-exercise tolerance as
well as decreased gene expression.
In summary, patients with CKD have reduced skeletal muscle gene expression in response
to a single bout of exercise which is not changed by improved renal function after transplanta-
tion. Despite a significant decrease in inflammatory markers post-transplant, insulin sensitiv-
ity, and gene expression in response to exercise including the NFAT/calcineurin pathway was
not improved post-transplant. Even though this study demonstrates reduced gene expression
responses in skeletal muscle of patients with CKD before and after kidney transplant, the
mechanism is yet to be defined. The clinical impact of these findings needs to be validated in a
larger cohort.
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S1 Table. DAVID analysis of gene expression after (A) one bout of exercise before transplant;
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plant that had at least a 1.5-fold greater expression before transplant.
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